# Patient-derived Glioma Stem Cell Organoids

> **NCT04868396** · — · ACTIVE_NOT_RECRUITING · sponsor: **Maastricht Radiation Oncology** · enrollment: 60 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Tumor biopsy

## Key facts

- **NCT ID:** NCT04868396
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-10
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868396, "Patient-derived Glioma Stem Cell Organoids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04868396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*